Skip to main content
PLOS Neglected Tropical Diseases logoLink to PLOS Neglected Tropical Diseases
. 2025 Aug 25;19(8):e0013410. doi: 10.1371/journal.pntd.0013410

Histoplasma capsulatum in wild mammals from Ecuador

Fernanda Hernández-Alomía 1,#, Jorge Brito 1,#, Ana Lucia Pilatasig 2, Daniela Reyes-Barriga 1, Julio C Carrión-Olmedo 1, Pablo Jarrín-V 1, Pablo Sánchez 1, Santiago F Burneo 2, Maria Alejandra Camacho 2, David Vasco-Julio 3, Manuel Calvopiña 4, Jacobus H De Waard 4, Daniel Romero-Alvarez 1,5,#, Carlos Bastidas-Caldes 6,*
Editor: Angel Gonzalez7
PMCID: PMC12404641  PMID: 40853991

Abstract

Background

Histoplasma capsulatum is a globally distributed dimorphic fungal pathogen endemic to the Americas, Africa, and Asia. It causes histoplasmosis, a disease acquired via inhalation of spores from contaminated environments. It thrives in nitrogen-rich soils and is disseminated by avian and chiropteran reservoirs. Histoplasma capsulatum has been found in wild mammals such as rodents, marsupials, felines, and xenarthrans, suggesting diverse reservoirs that may influence its maintenance and transmission in endemic areas. This study aimed to detect H. capsulatum in tissues of wild small mammals sampled across Ecuador.

Methods

Tissue samples (n = 324) were collected from wild mammals across the Coast, Andean, and Amazon regions between 2022 and 2023. Species were identified morphologically and H. capsulatum was detected using nested PCR targeting the 100-kDa protein-encoding gene. Positive samples were sequenced and analyzed. Ecological niche modeling focused on environmental clustering, via one class support vector machine (OC-SVM) hypervolumes, identified regions suitable for fungal survival.

Results

H. capsulatum was detected in 14% of samples in 30 of 106 species studied, predominantly in Chiroptera (80%) followed by Rodentia (15%) and Didelphimorphia (4%). Suitable environmental conditions were concentrated in Ecuador’s Coast region with isolated patches in the Andean and Amazon regions.

Conclusion

This study documents the broad host range and ecological distribution of H. capsulatum in Ecuador, reinforcing concerns about its zoonotic potential. The detection of the fungus across diverse mammalian taxa and ecosystems emphasizes the importance of wildlife-based surveillance to better understand fungal pathogen reservoirs and geographic hotspots.

Author summary

Histoplasmosis is a fungal disease that humans can get by breathing tiny spores from soil or animal droppings. The fungus, Histoplasma capsulatum, grows in nutrient-rich environments and is often linked to bats and birds. However, little is known about how it persists in wildlife in Ecuador. In this study, we collected tissue samples from small wild mammals across Ecuador’s Coast, Andes, and Amazon regions. Using DNA-based methods, we detected Histoplasma in several species, with most positive animals being bats, followed by rodents and opossums. We also analyzed environmental conditions and identified regions of Ecuador where the fungus is most likely to survive. Our findings show that Histoplasma is widespread in different mammal species and ecosystems, which highlights the importance of wildlife monitoring to better understand where this fungus lives and to reduce the risk of disease in people living in endemic areas.

Introduction

Histoplasma is a genus representing a worldwide thermal dimorphic fungal pathogen mainly found across the Americas, Africa, and Asia [1]. One of the most important species of this genus, H. capsulatum, is considered a causative agent of histoplasmosis, which is acquired by inhalation of spores from contaminated soil. The infectious cycle involves the inhalation of infective mycelial spores, which undergo a thermally regulated transition to the yeast form upon entering the host. This dimorphic shift is essential for intracellular survival and replication within macrophages and other phagocytes and is followed by the dissemination of the fungus back to the environment through carcasses, urine, and feces of infected animals [2]. It is suspected that histoplasmosis outbreaks may be attributable to environmental disruption, climate change, and human land use [3]. Histoplasma capsulatum is known to grow in nitrogen and phosphate enriched environments, such as those with bird and bat guano [4]. Moreover, it can be dispersed by avian and chiropteran species, which might act as long-range migratory reservoirs [4].

South and Central America contributes to the majority of human and animal histoplasmosis cases worldwide. Brazil has made significant contributions to histoplasmosis research, including reports of H. capsulatum isolation from various animals and soil samples across seven states [57]. Histoplasmosis is prevalent in wild animals, including rodents, marsupials, felines, xenarthrans, and others, as well as domestic animals such as bovines, equines, sheep, dogs, and cats [8,9]. Apart from Brazil, little research has been done in Latin America with limited reports on clinical or animal studies in countries like Colombia [10], Peru [11], Venezuela [12], and Mexico [13,14].

In Ecuador, histoplasmosis has been historically underdiagnosed, although an increasing number of clinical reports suggest a broader distribution than previously recognized. In people living with HIV, a retrospective study documented multiple cases of disseminated histoplasmosis, highlighting its importance as an opportunistic infection [15]. Several hospital-based studies have further described probable and histologically confirmed cases in immunocompetent individuals presenting with respiratory or systemic symptoms in various regions of the country [1618]. A fatal pediatric histoplasmosis case was reported in 2023, involving prolonged fever, hemorrhagic diarrhea, and persistent anemia [19]. Moreover, a 2015 report described a dog presenting with multifocal lymphadenitis and mucocutaneous lesions, in which H. capsulatum was identified as the causative agent [20].

Notably, most human cases reported in South America are associated with rural settings with a heightened likelihood of contact with wildlife. Consequently, the World Health Organization (WHO) encourages countries to strengthen monitoring of wildlife diseases as approximately 70% have a zoonotic origin [21]. Despite the relevance of the animal interface for spillover events, no studies on wild animals have been performed for H. capsulatum in Ecuador.

The concept of Primary Pandemic Prevention (PPP), introduced in the aftermath of the COVID-19 pandemic, emphasizes the early detection and surveillance of pathogens in animal populations—particularly in wildlife—as a critical measure to prevent zoonotic spillovers [22]. This perspective is inherently aligned with the One Health approach, which advocates for the integrated management of human, animal, and environmental health to address the complex dynamics of emerging infectious diseases [23]. Within this framework, the zoonotic potential of H. capsulatum remains insufficiently characterized. The present study aims to contribute to this gap by identifying the presence of the fungus in tissues of wild mammals sampled across 19 provinces of Ecuador, spanning the Coast, Andean, and Amazon regions.

Methodology

Ethics statement and permits

All fieldwork and specimen collection were conducted in compliance with Ecuadorian environmental and bioethical regulations. The general collection was authorized under the framework contract for access to genetic resources, issued by the National Biodiversity Directorate (Dirección Nacional de Biodiversidad in spanish) of the Ministry of Environment, Water and Ecological Transition (MAATE) which also served as the Institutional Review Board overseeing the study. Bats were captured and euthanized following the protocols of the QCAZ Museum under permit MAAE-DBI-CM-2021–0165. Terrestrial rodents and other small non-volant mammals were collected and euthanized by INABIO, operating under permit MAAE-DBI-CM-2023–0334. In the case of armadillos, tissues were obtained from a previously authorized study (MAAE-DBI-CM-2021–0172) in which hunters donated armadillos’ organs. In Ecuador, indigenous communities in rural regions can legally use bushmeat as protein sources for subsistence, a common practice that it is recognized under national regulations.

Sample site and specimen collection

Ecuador is divided into three climatic regions: Coast, Andean, and Amazon regions. Sampling efforts were conducted throughout the country between January 2022 and August 2023. Sampling sites include protected natural areas, secondary forests—influenced by agricultural activity—and highly deforested areas in rural Ecuador.

Collection techniques varied depending on the order of mammals collected. For bats (Chiroptera), a total of 18 mist nets were installed for a period of ten consecutive nights in a variety of locations, including agricultural fields and secondary forests. The mist nets were placed at ground level in areas with a high probability of bat capture, such as foraging sites, roosts, streams, and caves. The mist nets were left open for seven hours each night.

The capture of non-volant mammals, comprising rodents (Rodentia), opossums (Didelphimorphia), rabbits (Lagomorpha), marsupial mice (Paucituberculata), and shrews (Eulipotyphla) was conducted in multiple locations within Ecuador. To capture animals, live traps—one hundred Sherman and 15 Tomahawk traps—were utilized along transects spanning approximately 200 meters. A pitfall trap system was utilized at each location to optimize the efficacy of trapping. This entailed the use of a line comprising ten buckets (20 L capacity) buried at ground level and crossed by a plastic barrier approximately 60 m long and 0.5 m high [24]. Sherman, Tomahawk, and pitfall traps were baited with a mixture of oats, vanilla extract, and coconut. Armadillo specimens (Cingulata) were procured directly from hunters in rural regions of Ecuador who donated armadillo organs as part of a different study [25].

Morphological species identification and tissue sampling

The handling of captured individuals followed the protocols established by the Mammalogy Division of the Museum of Zoology of the Pontifical Catholic University of Ecuador (i.e., QCAZ) [26] and the guidelines of the American Society of Mammalogists [27,28]. Specimens were euthanized via cervical dislocation, adhering strictly to the ethical protocols outlined by Sikes et al. [28] and Erazo et al. [27]. Rodent and marsupial specimens were deposited at the Ecuadorian National Institute of Biodiversity (i.e., INABIO, in Spanish) in Quito, Ecuador. Identification of rodents was conducted following the methods described by Patton et al. [29], while marsupial identification adhered to the protocols of Voss and Giarla [30]. Armadillos were identified using molecular methods detailed in [25]. Collected specimens, along with tissue samples (liver, intestine, and muscle), were individually preserved in 75% ethanol to ensure proper conservation.

Molecular procedures

The DNA extraction was conducted using glass milk methodology, a silica-based method which uses silicon dioxide (SiO2) powder in a guanidine–HCl solution [31]. Ten milligrams of the target tissue were subjected to a preliminary treatment with Tris-HCl (10 mM, pH 8.0) and 20 mg/mL proteinase K, and then incubated overnight at 50°C. On the subsequent day, 200 µL of 2X concentrated glassmilk binding buffer and TE (10/1) were added to the sample and incubated for 20 minutes at 65°C. A volume of 200 µL of isopropanol was then added and the mixture was subjected to centrifugation at 12,000 rpm for one minute. The resulting pellet was resuspended in 500 μL of the Wash Buffer and centrifuged again at 12,000 rpm for 1 minute. This step was repeated twice. The pellet was then washed with 70% ethanol, centrifuged, and discarded. The remaining ethanol was allowed to dry at 65°C for 5–10 minutes until it completely evaporated. Finally, the pellet was resuspended in 200 µL of TE and stored overnight at 4°C. The supernatant was transferred to a new microtube and stored at -20°C for further use in molecular analyses [31].

For the identification of the 100-kDa protein-coding gene of H. capsulatum, a nested PCR was performed. For the first PCR, HcI (5-GCGTTCCGAGCCTTCCACCTCAAC-3) and HcII (5-ATGTCCCATCGGGCGCCGTGTAGT-3) primers were used to amplify a region of 391 base pairs (bp). For the second PCR, the primers used were HcIII (5-GAGATCTAGTCGCGGCCAGGTTCA-3) and HcIV (5-AGGAGAGAACTGTATCGGTGGCTTG-3), resulting in a PCR product of 210 bp. For this stage, the product of the first PCR was used as DNA template. Amplification was performed in reactions of 20 µL containing 1X GoTaq Green Master Mix (Promega) and 0.4 µM of each primer. The PCR protocol was followed as stated by Bialek et. al [32].

Sequencing analysis and Identification

The second PCR products (210 bp) were sequenced using the Sanger technique on an ABI 3500xL Genetic Analyzer (Applied Biosystems, Foster City, CA, USA) with BigDye 3.1 Terminator and a capillary electrophoresis matrix. PCR products were purified by enzymatic purification with Exo I and FastAP [33]. Sequences were edited using MEGA X software [34] and compared against sequences available at the GenBank database at the National Centre for Biotechnology Information (NCBI) through the Basic Local Alignment Search Tool (BLAST) [35]). Sequences were deposited in the NCBI database which assigned the following accession numbers: OR242319-OR242355; PP669556-PP669565.

Statistical analysis

All statistical analyses were performed using R software (version 4.4.1). To determine whether the prevalence of H. capsulatum varied significantly among wild mammal taxonomic orders, a global Chi-square test of independence was applied. Further, we calculated Chi-square tests comparing one H. capsulatum positive order versus all the other positive orders combined. For both approaches, the null hypothesis assumed no association between host order and fungal detection status. Statistical significance was defined as p < 0.05.

Potential distribution of H. capsulatum

We used ecological niche models to suggest potential regions of environmental similarity in the country using one-class support vector machine (OC-SVM) hypervolumes as presence-only algorithm [36]. Occurrences of positive detections of H. capsulatum were combined with temperature, relative humidity, and chemical characteristics of soil as environmental predictors summarized with a principal component analysis (PCA) and using only those components collecting more than 85% of the variability (S1 Information). We modeled the potential environmental suitability of the pathogen assuming that positive detections in wildlife act as sentinels of environmental fungi spores; thus, the model represents regions of environmental suitability for H. capsulatum spore survival in Ecuador.

Results

A total of 325 tissue samples—including 309 liver, seven muscle, three kidney, three fecal, and two spleen samples, plus a unique lung sample—were collected from wild mammals belonging to at least seven taxonomic orders and 106 species across the Ecuadorian Coast, Andes, and Amazon regions between 2022–2023 (S1 Table). The samples collected included 182 individuals from the order Rodentia, 70 from Chiroptera, 37 from Cingulata, 19 from Paucituberculata, 14 from Didelphimorphia, two from Eulipotyphla, and one from Lagomorpha.

The geographic distribution of mammalian specimens encompassed the three ecological regions of Ecuador (Coast, Andean, and Amazon) providing comprehensive nationwide coverage. The highest sampling effort was concentrated in the Amazon and Andean regions, with Chiroptera representing the most collected specimens. Other mammalian orders, such as Didelphimorphia and Rodentia, were sampled in smaller numbers but distributed across the three regions as well (Fig 1).

Fig 1. Distribution of examined mammalian species in Ecuador across ecological regions.

Fig 1

Panel A represents the sampling magnitude of mammal specimens across the Amazon rainforest, Andean highlands, and Coast lowlands. Panel B illustrates the frequency of Histoplasma capsulatum detected in mammalian tissues within these regions. Ecuador, located on the equatorial line northwest of South America, provides this study’s unique geographic and ecological context.

Positive detections were identified as H. capsulatum through sequencing (S2 Table). Overall, H. capsulatum was present in 14.1% (n = 46/325) of the evaluated samples, distributed across the three regions of Ecuador. Positive cases were detected in three of the seven mammalian orders assessed, encompassing 28% (30/106) of the species examined and showing a statistical association between mammalian order and fungal detection (χ² = 86.056, df = 2, p < 0.0001, S3 Table). Among these, Chiroptera demonstrated the highest prevalence, with 80% positive samples (n = 37/46; χ² = 62.839, df = 2, p < 0.0001, S3 Table), followed by Rodentia with 15.22% positives (n = 7/46; χ² = 23.12, df = 2, p < 0.0001, S3 Table) and Didelphimorphia with 4.34% positives (n = 2/46; χ² = 0.095, df = 2, p = 0.953, S2 Table). Remarkably, a single positive case was detected from a wild mouse in the fluvial highlands of Cubilines, Chimborazo, in the Andean region. In contrast, no H. capsulatum was detected in Eulipotyphla, Lagomorpha, Cingulata, and Paucituberculata species.

Among the H. capsulatum-positive samples, the pathogen was detected in 20 out of 27 identified species of Chiroptera, seven out of 63 species of Rodentia, and two out of nine species of Didelphimorphia (Tables 1 and S1). Additionally, two positive bat specimens could not be taxonomically identified using available classification keys. Notably, this study provides the first documented evidence of H. capsulatum infection in two opossum species, six rodent species, and 14 bat species in Ecuador, incriminating newer wild species and expanding the known host range of this pathogen. A comprehensive summary of the species, geographic regions, altitudes, and tissue types associated with positive H. capsulatum detections is detailed in Table 1.

Table 1. Prevalence of Histoplasma capsulatum in wild mammal hosts from Ecuador. Acronyms: masl = meters above sea level.

Order
(%; n/N)
Positive host species (n) Prevalence
(%)
Source/tissue Elevation (masl) Ecuadorian region Previous reports Country (Reference)
Didelphimorphia
14.3 (2/14)
Marmosa germana* (1) 100 (1) Liver 2750 Andean N/A
Monodelphis sp.* (7) 1/7 Liver 450 Coast N/A
Rodentia
3.85 (7/182)
Handleyomys alfaroi* (3) 33.3 (1) Liver 449 Coast N/A
Hylaeamys tatei* (2) 50(1) Liver 1284 Amazonia N/A
Microryzomys minutus* (11) 9.1(1) Liver 2919 Andean N/A
Neomicroxus latebricola* (2) 50(1) Liver 2956 Andean N/A
Oecomys sp. (7) 14.3(1) Liver 1262 Andean Brazil [5]
Oligoryzomys sp.* (1) 100 (1) Liver 2956 Andean N/A
Thomasomys paramorum* (12) 8.3 (1) Liver 3893 Andean N/A
Chiroptera
53.62 (37/69)
Artibeus fraterculus (1) 100 (1) Liver 193 Coast N/A
Artibeus literatus (2) 50(1) Liver 200 Coast Brazil [6,7]
Artibeus ravus* (4) 50(2) Liver, feces 200 Coast N/A
Carollia brevicaudum * (12) 50(6) Liver 193 - 200 Coast N/A
Carollia castanea* (6) 50(3) Liver 193 - 200 Coast N/A
Carollia perspicillata (6) 83.3 (5) Liver 200 Coast Colombia, Panama, Brazil, Trinidad [3743]
Eptesicus innoxius* (1) 100 (1) Liver 200 Coast N/A
Glossophaga soricina (6) 50 (3) Liver 193 Coast Panama, Brazil, Trinidad [6,3840,42,43]
Lonchophylla concava* (1) 100 (1) Liver 200 Coast N/A
Lonchorhina aurita (1) 100 (1) Liver 200 Coast Panama [39,42]
Micronycteris cf. Giovanniae* (1) 100 (1) Liver 1100 Andean N/A
Myotis nigricans (4) 25 (1) Liver 193 Coast Brazil [6]
Phyllostomus discolor (1) 100 (1) Liver 200 Coast Panama, El Salvador [39,43]
Platyrrhinus dorsalis cf.* (1) 100 (1) Liver 200 Coast N/A
Platyrrhinus umbratus* (4) 25 (1) Liver 200 Coast N/A
Rhinophylla alethina* (3) 66.6 (2) Liver 200 Coast N/A
Sturnira bakeri cf.* (1) 100 (1) Liver 193 Coast N/A
Sturnira luisi* (1) 100 (1) Liver 200 Coast N/A
Uroderma convexum* (1) 100 (1) Liver 200 Coast N/A
Vampyressa thyone* (1) 100 (1) Liver 200 Coast N/A
Unidentified (3) 66.6 (2) Liver, feces 193-200 Coast N/A

Note: * Indicates species in which Histoplasma capsulatum is reported for the first time.

The detection of H. capsulatum exhibited marked spatial variation, with the highest frequencies—up to 25 positive cases per site—observed in the northern Coast and specific areas of the Andean region. Lower detection frequencies, ranging from 1 to 11 cases, were recorded in the Amazon. Details regarding the sampling effort magnitude and the frequency of positive detections for H. capsulatum are provided in Fig 1 and S1 Table.

Ecuadorian regions with environments similar to those where H. capsulatum-positive cases were detected are primarily concentrated in the Coast region, northern Ecuador, where the largest area of continuous suitability was predicted (Fig 2). Additional areas of continuous suitability extend into parts of the Andean region, particularly in its western and central zones, as well as in the Coast lowlands. Discontinuous, patchy areas of suitability were also identified in the southern Coast region and in the eastern portion of the Amazon, where fragmented areas of predicted presence were observed (Fig 2).

Fig 2. Potential distribution of Histoplasma capsulatum based on environmental clustering.

Fig 2

Environmental suitability was modeled using one-class support vector machine (OC-SVM) hypervolumes to identify clusters in environmental space (A), represented by principal components (PC1, PC2, and PC3), and later projected onto the geographic landscape of Ecuador (B). The geographic projection highlights suitability categories (low, medium, and high) across regions, with high suitability areas primarily concentrated in northern Ecuador, spanning the Coast and Andean regions. Pink dots indicate locations where H. capsulatum was detected. Figure was developed using the packages alphahull and ggplot2 in R programming language and the official shapefile of Ecuador developed by the Technical Secretary of the National Committee on Internal Limits (CONALI in Spanish), available at: https://www.gob.ec/conali”.

Discussion

This study presents compelling evidence for the occurrence of H. capsulatum in wild mammals distributed across the three Ecuadorian continental regions. The analysis revealed a prevalence of 14% among the wild mammal samples examined. In this study, H. capsulatum was identified in 30 of the106 individual species studied.

The identification of bats, rodents, and marsupials as carriers of this pathogen is paramount. The elevated prevalence of H. capsulatum among Chiroptera (80%) highlights their potential role as primary reservoirs, particularly in anthropogenically disturbed forested habitats. We found a statistically significant association between Chiroptera and H. capsulatum detection (χ² = 62.84, p < 0.0001), indicating that bats are more affected compared to other mammalian groups.

Of the 27 bat species sampled, 20 were identified as reservoirs of H. capsulatum (Table 1). Previous studies have documented multiple Chiroptera species as reservoirs [5,44]. Notably, this study reports the detection of H. capsulatum in 13 additional bat species, predominantly concentrated in the Coast and Andean regions of Ecuador. The high diversity of bat species harboring H. capsulatum suggests the potential existence of additional, yet unidentified, wildlife reservoirs for this pathogen.

In the Americas, H. capsulatum has been described previously in three of the host orders studied here, including Chiroptera [14,37], Rodentia [45,46], and Didelphimorphia [5,47]. In previous studies, H. capsulatum has been found in the viscera of Didelphis albiventris, a widely distributed marsupial, and in liver and spleen samples from introduced rats (Rattus rattus) and two other marsupials (Metachirus opossum) in Rio de Janeiro [5]. H. capsulatum was also isolated from captive maras (Dolichotis patagonum) in Mexico, with soil samples from their cages identified as the probable source of infection. In our study, despite Didelphimorphia was found positive for H. capsulatum, the association with fungal status was not statistically significant (χ² = 0.096, p = 0.953) in comparison with the other orders assessed, suggesting that it might be less important as reservoir for H. capsulatum. On the other hand, Rodentia showed a significant association with fungal detection (χ² = 23.12, p < 0.0001), suggesting a higher likelihood of infection in this group, possibly due to their wide distribution, high adaptability, and the social behavior observed in the majority of wild mice species, characteristics shared by many bats [48]. We detected H. capulatum in the wild mouse Thomasomys paramorum at 3,893 masl (Table 1 and Fig 2), which is a theoretical atypical environment for spore survival. However, H. capsulatum has been identified in colder environments, specifically it has been detected in soil and penguin excreta in the Antarctic Peninsula [49], Both arguments hint over the potential remarkable adaptability of H. capsulatum for environments and reservoirs.

Although H. capsulatum has been previously reported in armadillo tissues in studies conducted in Brazil [50,51], the samples in our analysis were negative for the pathogen. Furthermore, a related fungus, Paecilomyces lilacinus, was isolated from the nine-banded armadillo (Dasypus novemcinctus) and initially resembled H. capsulatum in impression films and smears in a study of 1984 [52]. These findings highlight the importance of considering various animal species as potential reservoirs for H. capsulatum and related fungi in different regions [5,43,48].

Most of H. capsulatum detections were identified in intervened forest areas near paddocks which might have increased the risk of spore dispersal to humans and wildlife. Despite the paucity of detailed information regarding human infections with H. capsulatum from bats in Ecuador, some cases have documented instances of infection among individuals who have visited caves with large bat colonies in the Amazon region [53]. Furthermore, a fatal case of a children infected in the coastal tropical region of Ecuador was published and initially misdiagnosed as visceral leishmaniasis. The immunocompromised patient had a history of exposure to guano in the vicinity of fruit trees, underscoring the potential for environmental reservoirs to contribute to misdiagnose fungal infections, particularly in vulnerable populations [20].

The algorithm used in the ecological niche model developed here can find environmental clusters [36] which is a step forward in classic approaches to spatial epidemiology which only focuses on geographic distances [54]. We leverage H. capsulatum identifications to suggest future regions of sampling considering the lack of studies of H. capsulatum in Ecuador and the limited resources to study fungi or other pathogens in wildlife. The model suggests that Ecuador’s northern Andean and Coast region might be a pivotal area of environmental suitability for H. capsulatum. Identifications of the pathogen in the provinces of central Andes were neglected from the overall model suitability surface despite the development of 11 different predictions (S1 Information). Due to the scarcity of data and the inherent difficulties of detecting pathogens in wildlife, our models can be used as a first attempt to lead evidence-based sampling [25]. Species distribution models will greatly benefit from future field studies testing in-silico predictions such as the one presented here.

One health perspectives

The identification of H. capsulatum across multiple mammalian orders highlights its zoonotic potential and underscores the importance of monitoring wildlife as sentinels for environmental pathogens. Thus, Primary Pandemic Prevention (PPP) is particularly relevant in this context, emphasizing the importance of proactive surveillance of fungal pathogens. Given that histoplasmosis often mimics other pulmonary and systemic diseases, misdiagnosis can result in significant morbidity and mortality, particularly in immuno-compromised populations [9].

Bats, as key reservoirs of H. capsulatum, play an integral role in trophic chains and provide essential ecosystem services, such as pollination, seed dispersal, and insect population control, which are vital for the health and sustainability of forests. However, areas where bat guano accumulates, such as caves or community dwellings near roots, pose a significant risk for the transmission of H. capsulatum in humans. To minimize these risks, public health strategies should include educational programs emphasizing safe practices when visiting caves for tourism or other activities. These practices could involve the use of protective gear, proper ventilation in guano-rich environments, and limiting access to sensitive areas to reduce spore dispersal.

Study limitations

This study has several limitations. First, species sampling across all taxa is limited given constraints related to the conservation status of certain species, their vulnerability, restricted access to remote areas, and the regulatory requirements for collection permits. Accordingly, collection protocol prevented the capture or euthanasia of pregnant females or juvenile mammals. Despite these limitations, our findings provide valuable insights into the prevalence of H. capsulatum across a broad diversity of wild mammalian hosts (i.e., 106 species).

A further limitation was the inability to perform lineage-level identification of H. capsulatum via multilocus sequence typing (MLST). Because the tissue samples originated from preserved museum specimens and opportunistic field collections, fungal culture was unfeasible, thereby excluding the use of housekeeping genes required for MLST analyses. Future studies should prioritize the use of fresh samples and fungal isolation to enable genomic characterization and a deeper understanding of the evolutionary dynamics and transmission ecology of H. capsulatum in wildlife. Finally, the ecological niche model presented here should be considered as preliminary considering the lack of systematic sampling of any of the mammalian orders. However, by using this methodology we are taking advantage of bioinformatic analyses to predict regions of future collection studies specifically aimed at recovering H. capsulatum spores from the environment.

Conclusion

This study documents the broad host range and distribution of H. capsulatum in Ecuador, reinforcing concerns about its zoonotic potential. The detection of the fungus across diverse mammalian taxa and ecosystems emphasizes the importance of wildlife-based surveillance to better understand fungal pathogen reservoirs and geographic hotspots.

Supporting information

S1 Information. Detailed methods of ecological niche modeling.

(DOCX)

pntd.0013410.s001.docx (27.8KB, docx)
S1 Table. Complete dataset of host species and fungal detection results.

(XLSX)

pntd.0013410.s002.xlsx (30.3KB, xlsx)
S2 Table. Accession numbers and sequences of H. capsulatum positive samples.

(XLSX)

pntd.0013410.s003.xlsx (11KB, xlsx)
S3 Table. Chi-square Test.

Contingency tables and expected and observed frequencies by host orders.

(XLSX)

pntd.0013410.s004.xlsx (10.3KB, xlsx)

Data Availability

All relevant data are in the manuscript and its supporting information files.

Funding Statement

This study was funded by the Universidad de Las Américas (UDLA) under Research Project 486.B.XIV.24, directed by CBC. (Funder website: https://www.udla.edu.ec). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Wilmes D, Mayer U, Wohlsein P, Suntz M, Gerkrath J, Schulze C, et al. Animal Histoplasmosis in Europe: Review of the Literature and Molecular Typing of the Etiological Agents. J Fungi (Basel). 2022;8(8):833. doi: 10.3390/jof8080833 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Taylor ML, Reyes-Montes MDR, Estrada-Bárcenas DA, Zancopé-Oliveira RM, Rodríguez-Arellanes G, Ramírez JA. Considerations about the Geographic Distribution of Histoplasma Species. Appl Environ Microbiol. 2022;88(7):e0201021. doi: 10.1128/aem.02010-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Gnat S, Łagowski D, Nowakiewicz A, Dyląg M. A global view on fungal infections in humans and animals: infections caused by dimorphic fungi and dermatophytoses. J Appl Microbiol. 2021;131(6):2688–704. doi: 10.1111/jam.15084 [DOI] [PubMed] [Google Scholar]
  • 4.Teixeira M de M, Patané JSL, Taylor ML, Gómez BL, Theodoro RC, de Hoog S, et al. Worldwide Phylogenetic Distributions and Population Dynamics of the Genus Histoplasma. PLoS Negl Trop Dis. 2016;10(6):e0004732. doi: 10.1371/journal.pntd.0004732 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.de Farias DM, Leite Barros F de N, Sampaio-Júnior FD, Dos Santos Cruz Vieira J, de Sousa Gonçalves T, da Costa Rodrigues A de N, et al. Molecular Detection of Histoplasma capsulatum in Small Wild Mammals, Dogs, and Cats from Areas of Remaining Forest in the Brazilian Amazon. Transbound Emerg Dis. 2023;2023:5943212. doi: 10.1155/2023/5943212 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Veloso SCS, Ferreiro L, Pacheco SM, Silva RRP da, Souza E de C, Machado G, et al. Pneumocystis spp. e Histoplasma capsulatum detectados em pulmões de morcegos das regiões Sul e Centro-Oeste do Brasil. Acta Sci Vet. 2014;42: 1–7. Available: https://www.redalyc.org/articulo.oa?id=289029240069 [Google Scholar]
  • 7.Dos Santos B, Langoni H, da Silva RC, Menozzi BD, Bosco S de MG, Paiz LM, et al. Molecular detection of Histoplasma capsulatum in insectivorous and frugivorous bats in Southeastern Brazil. Med Mycol. 2018;56(8):937–40. doi: 10.1093/mmy/myx138 [DOI] [PubMed] [Google Scholar]
  • 8.Almeida M de A, Almeida-Silva F, Guimarães AJ, Almeida-Paes R, Zancopé-Oliveira RM. The occurrence of histoplasmosis in Brazil: A systematic review. Int J Infect Dis. 2019;86:147–56. doi: 10.1016/j.ijid.2019.07.009 [DOI] [PubMed] [Google Scholar]
  • 9.Rodrigues AM, Beale MA, Hagen F, Fisher MC, Terra PPD, de Hoog S, et al. The global epidemiology of emerging Histoplasma species in recent years. Studies in Mycology. 2020;97:100095. doi: 10.1016/j.simyco.2020.02.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Ordóñez N, Tobón A, Arango M, Tabares A, De Bedout C, Gómez B, et al. Brotes de histoplasmosis registrados en el área andina colombiana. biomedica. 1997;17(2):105. doi: 10.7705/biomedica.v17i2.941 [DOI] [Google Scholar]
  • 11.Ajello L, Lazarus AS, Cornejo A, Moore JC. Studies on the occurrence ofHistoplasma capsulatumin Peru. Med Mycol. 1962;1(2):83–6. doi: 10.1080/00362176285190181 [DOI] [Google Scholar]
  • 12.Ajello L, Briceno Maaz T, Campins H, Moore JC. Isolation of histoplasma capsulatum from an oil bird (Steatornis caripensis) cave in Venezuela. Mycopathol Mycol Appl. 1960;12:199–206. doi: 10.1007/BF02051369 [DOI] [PubMed] [Google Scholar]
  • 13.Taylor ML, Granados J, Toriello C. Biological and sociocultural approaches of histoplasmosis in the State of Guerrero, Mexico. Mycoses. 1996;39(9–10):375–9. doi: 10.1111/j.1439-0507.1996.tb00157.x [DOI] [PubMed] [Google Scholar]
  • 14.Taylor ML, Chávez-Tapia CB, Vargas-Yañez R, Rodríguez-Arellanes G, Peña-Sandoval GR, Toriello C, et al. Environmental conditions favoring bat infection with Histoplasma capsulatum in Mexican shelters. Am J Trop Med Hyg. 1999;61(6):914–9. doi: 10.4269/ajtmh.1999.61.914 [DOI] [PubMed] [Google Scholar]
  • 15.Zurita J, Denning DW, Paz-Y-Miño A, Solís MB, Arias LM. Serious fungal infections in Ecuador. Eur J Clin Microbiol Infect Dis. 2017;36(6):975–81. doi: 10.1007/s10096-017-2928-5 [DOI] [PubMed] [Google Scholar]
  • 16.Reinoso Herrera JM, Seminario Vintimilla ME, Arias Deidán J. Caso Clínico: Histoplasmosis Cutánea Diseminada en un Paciente Inmunocomprometido. Rev Med HJCA. 2018;10(2):160–4. doi: 10.14410/2018.10.2.cc.25 [DOI] [Google Scholar]
  • 17.Valencia Sancho D, Loza Santillan J, Santana Vargas P, Zambrano-Achig P, Pérez Tasigchana F. Histoplasmosis Diseminada en paciente Inmunocompetentes. PFR. 2020;5(2). doi: 10.23936/pfr.v5i2.163 [DOI] [Google Scholar]
  • 18.Escobar-Palma H, Hidalgo-Briones T, Soffe-Pazmiño J, León-Tapia L. Histoplasmosis diseminada en pediatría. INSPILIP. 2021;:1–5. doi: 10.31790/inspilip.v5i2.39 [DOI] [Google Scholar]
  • 19.Ortiz-Yépez JR, Ortega-Paredes DA, Barba PM, Mafla-Endara PM, Zurita J. Systemic canine histoplasmosis: A case report from Ecuador. Med Mycol Case Rep. 2015;9:18–21. doi: 10.1016/j.mmcr.2015.06.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Calvopiña M, Toro M, Bastidas-Caldes C, Vasco-Julio D, Muñoz G. A Fatal Case of Disseminated Histoplasmosis by Histoplasma capsulatum var. capsulatum Misdiagnosed as Visceral Leishmaniasis-Molecular Diagnosis and Identification. Pathogens. 2023;12(9):1112. doi: 10.3390/pathogens12091112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.World Health Organization. Pandemic prevention, preparedness and response accord. 2024 [cited 26 Jan 2025]. Available: https://www.who.int/news-room/questions-and-answers/item/pandemic-prevention--preparedness-and-response-accord
  • 22.Plowright RK, Ahmed AN, Coulson T, Crowther TW, Ejotre I, Faust CL, et al. Ecological countermeasures to prevent pathogen spillover and subsequent pandemics. Nat Commun. 2024;15(1):2577. doi: 10.1038/s41467-024-46151-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Atlas RM. One Health: its origins and future. Curr Top Microbiol Immunol. 2013;365:1–13. doi: 10.1007/82_2012_223 [DOI] [PubMed] [Google Scholar]
  • 24.Brito J, Koch C, Percequillo AR, Tinoco N, Weksler M, Pinto CM, et al. A new genus of oryzomyine rodents (Cricetidae, Sigmodontinae) with three new species from montane cloud forests, western Andean cordillera of Colombia and Ecuador. PeerJ. 2020;8:e10247. doi: 10.7717/peerj.10247/supp-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Romero-Alvarez D, Calvopiña M, Cisneros-Vásquez E, Garzon-Chavez D, Warren AK, Bennett LS, et al. Mycobacterium leprae in Nine-Banded Armadillos (Dasypus novemcinctus), Ecuador. Emerg Infect Dis. 2024;30(12):2629–32. doi: 10.3201/eid3012.231143 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Morales-Martínez DM, Camacho MA, Burneo S. Distribution and morphometric variation of Micronycteris schmidtorum (Sanborn, 1935) (Chiroptera: Phyllostomidae) in North South America with the first record from Ecuador. Mastozool Neotrop. 2018. [Google Scholar]
  • 27.Erazo Sotomayor OS, Camacho MA, Zapata Ríos G, Salas JA, Rosero R. P, Cisneros-Vidal R, et al. Recomendaciones para el uso y manejo de mamíferos silvestres en investigaciones desarrolladas en Ecuador. Mamm aequatorialis. 2021;3. doi: 10.59763/mam.aeq.v3i.42 [DOI] [Google Scholar]
  • 28.Sikes RS, Animal Care and Use Committee of the American Society of Mammalogists. 2016 Guidelines of the American Society of Mammalogists for the use of wild mammals in research and education. J Mammal. 2016;97(3):663–88. doi: 10.1093/jmammal/gyw078 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Patton JL, Pardiñas UFJ, D’Elía G. Mammals of South America, Volume 2: Rodents. Chicago: The University of Chicago Press. 2015. [Google Scholar]
  • 30.Rasmussen T, Hudlebusch HR, Knudsen LM, Johnsen HE. FGFR3 dysregulation and clinical outcome in myeloma. Br J Haematol. 2003;120(1):166. doi: 10.1046/j.1365-2141.2003.03983_1.x [DOI] [PubMed] [Google Scholar]
  • 31.Vásquez Bonilla MM, Guerrero-Freire MS, Ledesma Y, Laglaguano JC, de Waard JH. A rapid and inexpensive 96-well DNA-extraction method from blood using silicon dioxide powder (Glassmilk). Biol Methods Protoc. 2024;9(1):bpae079. doi: 10.1093/biomethods/bpae079 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Bialek R, Feucht A, Aepinus C, Just-Nübling G, Robertson VJ, Knobloch J, et al. Evaluation of two nested PCR assays for detection of Histoplasma capsulatum DNA in human tissue. J Clin Microbiol. 2002;40(5):1644–7. doi: 10.1128/JCM.40.5.1644-1647.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Werle E, Schneider C, Renner M, Völker M, Fiehn W. Convenient single-step, one tube purification of PCR products for direct sequencing. Nucleic Acids Res. 1994;22(20):4354–5. doi: 10.1093/nar/22.20.4354 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms. Mol Biol Evol. 2018;35(6):1547–9. doi: 10.1093/molbev/msy096 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.McGinnis S, Madden TL. BLAST: at the core of a powerful and diverse set of sequence analysis tools. Nucleic Acids Res. 2004;32(Web Server issue):W20-5. doi: 10.1093/nar/gkh435 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Blonder B, Morrow CB, Maitner B, Harris DJ, Lamanna C, Violle C, et al. New approaches for delineating n‐dimensional hypervolumes. Methods Ecol Evol. 2017;9(2):305–19. doi: 10.1111/2041-210x.12865 [DOI] [Google Scholar]
  • 37.da Silva JA, Scofield A, Barros F de N, de Farias DM, Riet-Correa G, Bezerra Júnior PS, et al. Molecular detection of Histoplasma capsulatum in bats of the Amazon biome in Pará state, Brazil. Transbound Emerg Dis. 2021;68(2):758–66. doi: 10.1111/tbed.13740 [DOI] [PubMed] [Google Scholar]
  • 38.Hasenclever HF. Histoplasmosis in bats. Health Lab Sci. 1972;9(2):125–32. [PubMed] [Google Scholar]
  • 39.Shacklette MH, Hasenclever HF. Variation of rates of natural infection with Histoplasma capsulatum in bats. Am J Trop Med Hyg. 1969;18(1):53–7. doi: 10.4269/ajtmh.1969.18.53 [DOI] [PubMed] [Google Scholar]
  • 40.Emmons CW, Greenhall AM. Histoplasma capsulatumand house bats in Trinidad, W.I. Med Mycol. 1963;2(1):18–22. doi: 10.1080/00362176385190061 [DOI] [Google Scholar]
  • 41.Tesh RB, Schneidau JD Jr. Naturally occurring histoplasmosis among bat colonies in the Southeastern United States. Am J Epidemiol. 1967;86(3):545–51. doi: 10.1093/oxfordjournals.aje.a120764 [DOI] [PubMed] [Google Scholar]
  • 42.Diercks FH, Shacklette MH, Kelley HB Jr, Klite PD, Thompson SW, Keenan CM. Naturally occurring histoplasmosis among 935 bats collected in Panama and the Canal Zone, July 1961-February 1963. Am J Trop Med Hyg. 1965;14(6):1069–72. doi: 10.4269/ajtmh.1965.14.1069 [DOI] [PubMed] [Google Scholar]
  • 43.Klite PD, Diercks FH. Histoplasma capsulatum in fecal contents and organs of bats in the Canal zone. Am J Trop Med Hyg. 1965;14:433–9. doi: 10.4269/ajtmh.1965.14.433 [DOI] [PubMed] [Google Scholar]
  • 44.Gugnani HC, Denning DW. Infection of bats with Histoplasma species. Med Mycol. 2023;61(8):myad080. doi: 10.1093/mmy/myad080 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Menges RW, Furcolow ML, Habermann RT, Weeks RJ. Epidemiologic studies on histoplasmosis in wildlife. Environ Res. 1967;1(2):129–44. doi: 10.1016/0013-9351(67)90009-6 [DOI] [PubMed] [Google Scholar]
  • 46.Naiff RD, Barrett TV, Naiff M de F, Ferreira LC, Arias JR. New records of Histoplasma capsulatum from wild animals in the Brazilian Amazon. Rev Inst Med Trop Sao Paulo. 1996;38(4):273–7. doi: 10.1590/s0036-46651996000400006 [DOI] [PubMed] [Google Scholar]
  • 47.Zancopé-Oliveira RM, Wanke B. Isolamento do Histoplasma capsulatum de animais silvestres no município do Rio de Janeiro. Cad Saúde Pública. 1986;2(1):42–52. doi: 10.1590/s0102-311x1986000100004 [DOI] [Google Scholar]
  • 48.Luis AD, Hayman DTS, O’Shea TJ, Cryan PM, Gilbert AT, Pulliam JRC, et al. A comparison of bats and rodents as reservoirs of zoonotic viruses: are bats special?. Proc Biol Sci. 2013;280(1756):20122753. doi: 10.1098/rspb.2012.2753 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Moreira LM, Meyer W, Chame M, Brandão ML, Vivoni AM, Portugal J, et al. Molecular Detection of Histoplasma capsulatum in Antarctica. Emerg Infect Dis. 2022;28(10):2100–4. doi: 10.3201/eid2810.220046 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Arias JR, Naiff RD, Naiff MF, Mok WY, Almeida MM. Isolation of Histoplasma capsulatum from an armadillo (Dasypus novemcinctus) in the eastern Amazon of Brazil. Trans R Soc Trop Med Hyg. 1982;76(5):705–6. doi: 10.1016/0035-9203(82)90253-x [DOI] [PubMed] [Google Scholar]
  • 51.Naiff RD, Mok WY, Naiff MF. Distribution of Histoplasma capsulatum in Amazonian wildlife. Mycopathologia. 1985;89(3):165–8. doi: 10.1007/BF00447026 [DOI] [PubMed] [Google Scholar]
  • 52.Gordon MA. Paecilomyces lilacinus (Thom) Samson, from systemic infection in an armadillo (Dasypus novemcinctus). Sabouraudia. 1984;22(2):109–16. doi: 10.1080/00362178485380181 [DOI] [PubMed] [Google Scholar]
  • 53.Valdez H, Salata RA. Bat-associated histoplasmosis in returning travelers: case presentation and description of a cluster. J Travel Med. 1999;6(4):258–60. doi: 10.1111/j.1708-8305.1999.tb00529.x [DOI] [PubMed] [Google Scholar]
  • 54.Ostfeld RS, Glass GE, Keesing F. Spatial epidemiology: an emerging (or re-emerging) discipline. Trends Ecol Evol. 2005;20(6):328–36. doi: 10.1016/j.tree.2005.03.009 [DOI] [PubMed] [Google Scholar]
PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0013410.r001

Decision Letter 0

Angel Gonzalez

12 May 2025

Histoplasma capsulatum in Wild Mammals from Ecuador

PLOS Neglected Tropical Diseases

Dear Dr. Bastidas,

Thank you for submitting your manuscript to PLOS Neglected Tropical Diseases. After careful consideration, we feel that it has merit but does not fully meet PLOS Neglected Tropical Diseases's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript within 60 days Jul 11 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosntds@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pntd/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

* A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to any formatting updates and technical items listed in the 'Journal Requirements' section below.

* A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

* An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Angel Gonzalez, Ph.D.

Academic Editor

PLOS Neglected Tropical Diseases

Marcio Rodrigues

Section Editor

PLOS Neglected Tropical Diseases

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-4304-636XX

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-1765-0002

Journal Requirements:

1) Please ensure that the CRediT author contributions listed for every co-author are completed accurately and in full.

At this stage, the following Authors/Authors require contributions: Carlos Bastidas. Please ensure that the full contributions of each author are acknowledged in the "Add/Edit/Remove Authors" section of our submission form.

The list of CRediT author contributions may be found here: https://journals.plos.org/plosntds/s/authorship#loc-author-contributions

2) Please provide an Author Summary. This should appear in your manuscript between the Abstract (if applicable) and the Introduction, and should be 150-200 words long. The aim should be to make your findings accessible to a wide audience that includes both scientists and non-scientists. Sample summaries can be found on our website under Submission Guidelines:

https://journals.plos.org/plosntds/s/submission-guidelines#loc-parts-of-a-submission

3) We do not publish any copyright or trademark symbols that usually accompany proprietary names, eg ©,  ®, or TM  (e.g. next to drug or reagent names). Therefore please remove all instances of trademark/copyright symbols throughout the text, including:

- ® on page: 4 and 5.

4) Please upload all main figures as separate Figure files in .tif or .eps format. For more information about how to convert and format your figure files please see our guidelines: 

https://journals.plos.org/plosntds/s/figures

5) We have noticed that you have uploaded Supporting Information files, but you have not included a list of legends. Please add a full list of legends for your Supporting Information files after the references list.

6) Some material included in your submission may be copyrighted. According to PLOSu2019s copyright policy, authors who use figures or other material (e.g., graphics, clipart, maps) from another author or copyright holder must demonstrate or obtain permission to publish this material under the Creative Commons Attribution 4.0 International (CC BY 4.0) License used by PLOS journals. Please closely review the details of PLOSu2019s copyright requirements here: PLOS Licenses and Copyright. If you need to request permissions from a copyright holder, you may use PLOS's Copyright Content Permission form.

Please respond directly to this email and provide any known details concerning your material's license terms and permissions required for reuse, even if you have not yet obtained copyright permissions or are unsure of your material's copyright compatibility. Once you have responded and addressed all other outstanding technical requirements, you may resubmit your manuscript within Editorial Manager. 

Potential Copyright Issues:

- Figure 1. Please confirm whether you drew the images / clip-art within the figure panels by hand. If you did not draw the images, please provide (a) a link to the source of the images or icons and their license / terms of use; or (b) written permission from the copyright holder to publish the images or icons under our CC BY 4.0 license. Alternatively, you may replace the images with open source alternatives. See these open source resources you may use to replace images / clip-art:

- https://commons.wikimedia.org

- https://openclipart.org/.

- Figures 2 and 3. Please (a) provide a direct link to the base layer of the map (i.e., the country or region border shape) and ensure this is also included in the figure legend; and (b) provide a link to the terms of use / license information for the base layer image or shapefile. We cannot publish proprietary or copyrighted maps (e.g. Google Maps, Mapquest) and the terms of use for your map base layer must be compatible with our CC BY 4.0 license.

Note: if you created the map in a software program like R or ArcGIS, please locate and indicate the source of the basemap shapefile onto which data has been plotted.

If your map was obtained from a copyrighted source please amend the figure so that the base map used is from an openly available source. Alternatively, please provide explicit written permission from the copyright holder granting you the right to publish the material under our CC BY 4.0 license.

If you are unsure whether you can use a map or not, please do reach out and we will be able to help you. The following websites are good examples of where you can source open access or public domain maps:

* U.S. Geological Survey (USGS) - All maps are in the public domain. (http://www.usgs.gov)

* PlaniGlobe - All maps are published under a Creative Commons license so please cite u201cPlaniGlobe, http://www.planiglobe.com, CC BY 2.0u201d in the image credit after the caption. (http://www.planiglobe.com/?lang=enl)

* Natural Earth - All maps are public domain. (http://www.naturalearthdata.com/about/terms-of-use/).

Reviewers' Comments:

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: Phylogenetic analysis are not

Reviewer #2: Methods are not clear. Justification for collecting tissues (result.s site lung, liver, spleen and feces) but presenting on only liver in Table 1 is confusing. were other tissues not screened? Screened but not positive?

There is biased sampling , quantity of animals captured in one region may bias results.

Global Chi-square test may be inappropriate given the uneven distribution of species. what is the true abundance of the species in question? This test is assuming that you captured a representative set of host orders. wouldn't you test each order separately?

Approval for trapping and euthanasia was stated in manuscript

Reviewer #3: -Are the objectives of the study clearly articulated with a clear testable hypothesis stated? Yes

-Is the study design appropriate to address the stated objectives?

Comment: I would like to question the efficacy of the Hcp100 molecular marker for the phylogenetic analysis. The Hcp100 molecular marker is successfully used in clinical diagnosis and for searching the H. capsulatum presence in randomly infected animals, because this marker amplified a specific DNA fragment of 210 bp, in the second Nested-PCR reaction, which is unique for this fungal pathogen. Although its use for H. capsulatum phylogenetic analyses is not the most recommendable, mainly considering that the Hcp100 fragment presents very low polymorphism, clades obtained were certainly representative and discriminate the different groups of animals studied. Thus, I suggest including an appropriate interpretation in the Discussion section of the Manuscript.

-Is the population clearly described and appropriate for the hypothesis being tested? Yes

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested? Yes

-Were correct statistical analysis used to support conclusions? Please, see my comment

-Are there concerns about ethical or regulatory requirements being met? Yes

**********

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: Phylogenetic analysis are not

Reviewer #2: Percentage positivity is slightly misleading when only one representative of the species was captured.

Data in supplemental table doesn't seem to match Table 1 - what is the status of samples 294 and 317? is this collected from animal directly or was this from the cave floor? If the latter, this is an environmental sample

Due to the high similarity of these sequences and having only a single sequence from PCR, a phylogenetic tree is likely a poor methods to describe diversity. this is a ~180 bp fragment, so percent identity would be clearer. no branch support reported and provides little information on Histoplasma diversity in Ecuador.

The ecological niche model is not well described and could simply model species distribution rather that fungal distribution. Very confusing.

Reviewer #3: -Does the analysis presented match the analysis plan? Please, see my comment

-Are the results clearly and completely presented? Delete repetitive phrases in the Results section, I.e.: lines 240-242, - Sequences marked with an asterisk (PP669556, PP669558, OR242338) represent identical sequences found in other specimens analyzed in this study. Sequences marked with an asterisk (PP669556, 242 PP669558, OR242338) represent identical sequences found in other specimens analyzed in this study

-Are the figures (Tables, Images) of sufficient quality for clarity? Yes

**********

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: yes

Reviewer #2: The discussion is diffuse and sometimes confusing. The point that we know little about the range of potential infected animals is key, and I think the data collected support that. Focus on this. I think some statement of the limitations of the study and future directions would be useful.

Reviewer #3: -Are the conclusions supported by the data presented? Yes

-Are the limitations of analysis clearly described? Please, see my comment

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study? Please, see my comment

-Is public health relevance addressed? Yes

**********

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: (No Response)

Reviewer #2: There must be clearer description of methods, justification of tissues samples and improved statistical analysis, as suggested above.

Reviewer #3: Minor observation:

Delete repetitive phrases

I.e.: pages 240-242, - Sequences marked with an asterisk (PP669556, PP669558,

OR242338) represent identical sequences found in other specimens analyzed in

this study. Sequences marked with an asterisk (PP669556, 242 PP669558,

OR242338) represent identical sequences found in other specimens analyzed in

this study

**********

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: This manuscript addresses a highly relevant and timely topic by investigating Histoplasma capsulatum infection in a variety of wild mammalian hosts across Ecuador. The study provides valuable insights into the ecological distribution and potential zoonotic interfaces of H. capsulatum, contributing to ongoing discussions in medical mycology and One Health frameworks. However, while the core objectives are important, the manuscript still requires significant revisions to improve scientific rigor, methodological transparency, and interpretative depth. Several sections—including the abstract, introduction, methods, phylogenetic analysis, and discussion—would benefit from restructuring, clarification, and more robust contextualization within the existing literature. I outline specific comments and suggestions below to help the authors enhance the overall clarity, accuracy, and impact of their work.

Abstract:

Line 28 – The statement “is disseminated by avian and chiropteran reservoirs” appears to be overly speculative, particularly regarding avian hosts. While Histoplasma has been consistently detected in association with chiropteran reservoirs—supporting their role in its ecological dissemination—there is limited evidence implicating birds directly.

Line 29 – “H. capsulatum presence is prevalent in wild animals, including rodents, marsupials, felines, xenarthrans, and others.” The statement is vague and lacks a clear take-home message. While it lists various wild animal groups associated with H. capsulatum, it doesn't explain the ecological, epidemiological, or transmission relevance of this information. Suggestion: “Histoplasma capsulatum has been found in wild mammals such as rodents, marsupials, felines and xenarthrans, suggesting diverse reservoirs that may influence its maintenance and transmission in endemic areas. ”. Please connect this to the next sentence.

Line 34 – the term “protein gene” is not commonly used in formal scientific writing. “H. capsulatum was detected using a nested PCR assay targeting the 100-kDa protein-encoding gene”

Line 35 - Ecological niche modeling - Which Method?

Line 40 – Improve conclusion. Suggestion: “ This study documents the broad host range and ecological distribution of H. capsulatum in Ecuador, reinforcing concerns about its zoonotic potential. The detection of the fungus across diverse mammalian taxa and ecosystems emphasizes the importance of wildlife-based surveillance to better understand fungal pathogen reservoirs and geographic hotspots”

Introduction

49 – Given the existence of multiple phylogenetic species within the Histoplasma genus, it is important to avoid generalizing H. capsulatum as a unique species.

51 - The description of the infectious cycle omits a pivotal phase in the pathogenesis of Histoplasma spp.—the transition from the mycelial to the yeast form (dimorphism) upon entering the host. This thermally regulated shift is critical for intracellular survival and virulence, particularly within macrophages. I recommend revising the sentence to explicitly include this phase, as it represents a fundamental step in the fungal life cycle and host adaptation.

53 - the reintroduction of the fungus into the environment??

60 – The sentence referencing Brazil’s contributions to histoplasmosis research contains critical grammatical and structural issues. I recommend rephrasing it for clarity and accuracy.

68 – The manuscript would benefit from a more comprehensive overview of the burden of histoplasmosis in Ecuador. As currently written, the mention of a single case gives the misleading impression that histoplasmosis is rare or poorly relevant in the country. However, this contradicts existing evidence. For instance, the study 10.1007/s10096-017-2928-5 highlights multiple cases of disseminated histoplasmosis in Ecuadorian patients with HIV, underscoring its clinical importance.

Line 78 - The concept of Primary Pandemic Prevention (PPP), as described here, is important and timely. However, I suggest that framing this within a One Health context may be more appropriate and impactful. One Health emphasizes the interconnectedness of human, animal (both domestic and wild), and environmental health, and has been widely adopted as a guiding framework for pandemic preparedness and zoonotic disease surveillance.

Line 83 - The final paragraph of the introduction would benefit from a more impactful closing that clearly states the study’s main findings and the broader implications of the knowledge gap being addressed. I recommend adding a sentence that emphasizes both the novelty of detecting Histoplasma across a diverse range of wild mammalian hosts in Ecuador and the public health relevance of these findings.

Methodology

89 – 109

This section raises two important concerns that require clarification. Animal Handling and Necropsy Procedures: The manuscript does not provide sufficient detail on how animals were euthanized or how necropsies were performed. For studies involving the collection of tissue samples from wild mammals, it is essential to specify the methods used for euthanasia (if applicable), as well as the procedures and biosafety measures applied during necropsy. This is critical for reproducibility, ethical transparency, and to ensure compliance with international animal welfare standards. Legality of Armadillo Acquisition: The collection of armadillo specimens from hunters or rural markets raises potential ethical and legal concerns. In many countries, including Ecuador, hunting and trade of wild mammals—especially for bushmeat—may be prohibited or tightly regulated. The authors should clarify whether this practice was conducted legally and under appropriate authorization. If specimens were sourced without proper documentation, this could present a serious ethical issue.

131 - a silica-based technique for nucleic acid purification?

134 - What is Magic Blue???

134-136 – Could the authors clarify whether DNA precipitation and wash was carried out at room temperature or at a lower temperature (e.g., 4 °C or −20 °C), which is standard to enhance nucleic acid yield?

137 - Could the authors specify the composition of the wash buffer used in the DNA extraction protocol?

148 - Please rephrase the sentence describing the PCR setup for clarity.

154 - The sentence refers to “BigDye 3.1® capillary electrophoresis matrix,” but this is technically inaccurate. BigDye Terminator v3.1® refers to the sequencing chemistry, not the electrophoresis matrix. Please revise the wording to accurately reflect that BigDye is the reagent used for Sanger sequencing, while the capillary electrophoresis matrix (e.g., POP-7 or POP-6) refers to the polymer used during fragment separation. Moreover, how PCR products were purified?? What is the size of the sequenced amplicons???? A lot of information is missing here.

Line 157 – It is unclear which sequences were used for comparison in the phylogenetic or identity analyses. I strongly recommend including a supplementary table listing all reference sequences used, along with their GenBank accession numbers, species identification, and relevant metadata.

Line 177 - The manuscript mentions temperature, relative humidity, and chemical characteristics of soil as environmental predictors. However, it is not clear how and where these environmental data were obtained. Were they measured in situ at each sampling location, retrieved from public databases, or modeled?

Results

Line 187 – indicate the total number of liver, spleen, lung, and feces samples

Line 211 - The statement that this is the first documented evidence of Histoplasma capsulatum infection in two opossum, six rodent and 14 bat species species is inaccurate. Which species? Please name the hosts even mnentioning Table 1.

Line 221-230 –

While the use of short sequences in phylogenetic analyses is often challenging due to limited phylogenetic signal, it is not inherently problematic when handled with appropriate methodological rigor. In this context, I recommend that the authors explicitly state the total number of Hc100 sequences used for tree construction and discuss potential limitations associated with sequence length.

To independently evaluate the robustness of the presented phylogeny, I reconstructed a maximum likelihood tree using IQ-TREE2 with the command -m TEST and support values estimated by both aBayes and 1,000 ultrafast bootstrap replicates. The Ecuadorian strains appear to cluster into two clades; however, the branching pattern between these groups may be artefactual or reflect insufficient resolution.

The presented tree herein discussed shows two clades. Notably, the upper clade (labeled in blue), which contains the majority of the sequences, clusters more closely with the reference strain H67 (associated with the LAm A2 lineage; see Kasuga et al., 2003). In contrast, the lower clade (yellow) is more closely related to strain H66, which has been associated with the LAm B lineage (Kasuga et al., 2003). Still there is a bias on the sequence length here. I strongly encourage the authors to re-express the phylogenetic relationships in light of these findings and consult prior literature that more comprehensively characterizes these lineages—particularly the work https://pubmed.ncbi.nlm.nih.gov/31372546/, which provides deeper insights into the genetic structure and population differentiation of colombian strains and is comparable to your dataset. See attached files

Another possibility is mention that strains are grouped into two different phylogenetic clusters without mentioning their genetic background.

I have no concerns about the species niche modeling.

Discussion

The discussion is generally well-written and informative; however, it would benefit from a deeper contextualization of the findings within a One Health framework. In particular, I recommend expanding the section to include more information on the burden and epidemiology of histoplasmosis in humans in Ecuador and neighboring regions. There is ample evidence that histoplasmosis is endemic in Ecuador, especially in immunocompromised individuals, including people living with HIV. Integrating this information would help situate the findings on opossum infection within a broader ecological and public health context, supporting the relevance of the study to One Health initiatives and pathogen surveillance strategies in the region.

Reviewer #2: While I think this could be a great contribution to the literature on Histoplasma in Ecuador, it needs significant improvement. In the introduction, there is a statement that birds and bats transmit Histoplasma via fecal route. While it is true that guano piles in caves and coops have been implicated sources of infection during outbreaks, there is still much debate on carriage. For the few studies that have directly collected from living animals, the rate of positivity is still low or zero. Dead animals are also found in guano piles thus Histoplasma could grow out of infected tissue, rather than dispersed via fecal route.

Reviewer #3: In regarding to the revision of the Manuscript MS PNTD-D-25-0030, entitled

"Histoplasma capsulatum in Wild Mammals from Ecuador", I would like to

emphasize its importance in the epidemiology of histoplasmosis, mainly

considering a wide sort of animals studied (106 species) and the role of wild

mammals as possible reservoirs and, particularly, the role of bats as the main

reservoir and disperser of the fungal pathogen H. capsulatum in nature, as have

been suggested by some researchers. Thus, any type of evidence for the

occurrence of H. capsulatum in wild mammals, either in Latin America or in other

regions or the world should be privileged. However, I would like to question the

efficacy of the Hcp100 molecular marker for the phylogenetic analysis. The Hcp100

molecular marker is successfully used in clinical diagnosis and for searching the H.

capsulatum presence in randomly infected animals, because this marker amplified

a specific DNA fragment of 210 bp, in the second Nested-PCR reaction, which is

unique for this fungal pathogen. Although its use for H. capsulatum phylogenetic

analyses is not the most recommendable, mainly considering that the Hcp100

fragment presents very low polymorphism, clades obtained were certainly

representative and discriminate the different groups of animals studied. Hence, I

suggest including appropriate interpretations in the Discussion section of the

Manuscript.

Overall, considering the above-comment, I think that the Manuscript must be

accepted.

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

Figure resubmission:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. If there are other versions of figure files still present in your submission file inventory at resubmission, please replace them with the PACE-processed versions.

Reproducibility:

?>

Attachment

Submitted filename: hc_100.nwk2.txt.pdf

pntd.0013410.s005.pdf (9.7KB, pdf)
Attachment

Submitted filename: hc_100.nwk.txt.pdf

pntd.0013410.s006.pdf (10.3KB, pdf)
Attachment

Submitted filename: hc100.fasta

pntd.0013410.s007.fasta (36.1KB, fasta)
PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0013410.r003

Decision Letter 1

Angel Gonzalez

30 Jul 2025

Dear Dr. Bastidas,

We are pleased to inform you that your manuscript 'Histoplasma capsulatum in Wild Mammals from Ecuador' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Angel Gonzalez, Ph.D.

Academic Editor

PLOS Neglected Tropical Diseases

Marcio Rodrigues

Section Editor

PLOS Neglected Tropical Diseases

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-4304-636XX

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-1765-0002

***********************************************************

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; line-height: 16.0px; font: 14.0px Arial; color: #323333; -webkit-text-stroke: #323333}span.s1 {font-kerning: none

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0013410.r004

Acceptance letter

Angel Gonzalez

Dear Sr. Bastidas-Caldes,

We are delighted to inform you that your manuscript, "Histoplasma capsulatum in Wild Mammals from Ecuador," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Information. Detailed methods of ecological niche modeling.

    (DOCX)

    pntd.0013410.s001.docx (27.8KB, docx)
    S1 Table. Complete dataset of host species and fungal detection results.

    (XLSX)

    pntd.0013410.s002.xlsx (30.3KB, xlsx)
    S2 Table. Accession numbers and sequences of H. capsulatum positive samples.

    (XLSX)

    pntd.0013410.s003.xlsx (11KB, xlsx)
    S3 Table. Chi-square Test.

    Contingency tables and expected and observed frequencies by host orders.

    (XLSX)

    pntd.0013410.s004.xlsx (10.3KB, xlsx)
    Attachment

    Submitted filename: hc_100.nwk2.txt.pdf

    pntd.0013410.s005.pdf (9.7KB, pdf)
    Attachment

    Submitted filename: hc_100.nwk.txt.pdf

    pntd.0013410.s006.pdf (10.3KB, pdf)
    Attachment

    Submitted filename: hc100.fasta

    pntd.0013410.s007.fasta (36.1KB, fasta)
    Attachment

    Submitted filename: Response Letter_PlosNTD.docx

    pntd.0013410.s008.docx (67.4KB, docx)

    Data Availability Statement

    All relevant data are in the manuscript and its supporting information files.


    Articles from PLOS Neglected Tropical Diseases are provided here courtesy of PLOS

    RESOURCES